42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-952823
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 2bfe88d4-e63e-43f8-bc98-9f5a28959d0f
[Document ID] => 952823
[Document naam] => 2020.11.09 - COVID-19 GSK Covid Solutions for Governments_FinalSelectie voor - -.pdf
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/document/VWS-WOO-08-952823
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-952823
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO
[DocumentPublicationDate] => 20 november 2020
[DocumentStatusCheckedDate] => 2026-04-27 20:51:11.325741
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:59:06
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:59:06
)
Document: VWS-WOO-08-952823
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201120
Geregistreerde documentnaam: 2020.11.09 - COVID-19 GSK Covid Solutions for Governments_FinalSelectie voor - -.pdf
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_documentName | 2020.11.09 - COVID-19 GSK Covid Solutions for Governments_FinalSelectie voor - -.pdf | 2025-06-30 02:20:21 |
| document_documentType | 2025-06-30 02:20:21 | |
| document_documentPublicationDate | 2020-11-20 | 2025-06-30 02:20:21 |
| document_documentNumber | VWS-WOO-08-952823 | 2025-06-30 02:20:21 |
| document_SectionDownloadButton | 0 | 2025-06-30 02:20:21 |
| document_SectionHTMLDataDivs | 2 | 2025-06-30 02:20:21 |
| document_SectionAbout | 1 | 2025-06-30 02:20:21 |
| About_Datum document | 20 november 2020 | 2025-06-30 02:20:21 |
| About_Type bronbestand | PDF, 5 pagina's | 2025-06-30 02:20:21 |
| About_Type bronbestand_paginas | 5 | 2025-06-30 02:20:21 |
| About_Download als | PDF (1.76 MB) | 2025-06-30 02:20:21 |
| About_Documentnummer | 952823 | 2025-06-30 02:20:21 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-30 02:20:21 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-30 02:20:21 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-30 02:20:21 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-30 02:20:21 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over 2020.11.09 - COVID-19 GSK Covid Solutions for Governments_FinalSelectie voor - -.pdf (documentnummer 1ee694b9-2b4e-6682-8231-2b7b8111b989) | 2025-06-30 02:20:21 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-30 02:20:21 |
| document_SectionRequest | 1 | 2025-06-30 02:20:21 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-30 02:20:21 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO | 2025-06-30 02:20:21 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-30 02:20:21 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 10 augustus 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode november 2020. | 2025-06-30 02:20:21 |
| Request_Periode | November 2020 | 2025-06-30 02:20:21 |
| Request_Type besluit | Woo-besluit | 2025-06-30 02:20:21 |
| Request_Datum besluit | 10 augustus 2022 | 2025-06-30 02:20:21 |
| Request_Omvang openbaarmaking | 8.199 documenten, 34.478 pagina's Inventarislijst | 2025-06-30 02:20:21 |
| Request_Omvang openbaarmaking_documenten | 8.199 | 2025-06-30 02:20:21 |
| Request_Omvang openbaarmaking_paginas | 34.478 | 2025-06-30 02:20:21 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/inventory | 2025-06-30 02:20:21 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 02:20:21 |
| DocumentDownload_linkname | Download (pdf, 1.76 MB) | 2025-04-20 00:35:23 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/document/1ee694b9-2b4e-6682-8231-2b7b8111b989 | 2025-04-20 00:35:23 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-952823.pdf | 2025-04-20 00:35:23 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-09-08 18:20:37
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-952823.pdf
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 1843927
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:20:37
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:20:37
lastSeen: 2025-09-08 18:20:37
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 276f7173742a91381bb1cf6b090812d3f2fbd7e891e899bd455aa7c21fbbf55e
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_617_976c3ccf6a39b85a7871c6646d9eaac2
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 2 — 2025-09-04 16:59:32
fromFile: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 1127532
documentSize: 1843927
documentCompressRatio: 61.14840771896068
documentDateModified: 2025-05-01 20:21:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:59:32
lastSeen: 2025-09-04 16:59:32
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 276f7173742a91381bb1cf6b090812d3f2fbd7e891e899bd455aa7c21fbbf55e
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip_989
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 3 — 2025-09-04 16:37:56
fromFile: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 1127532
documentSize: 1843927
documentCompressRatio: 61.14840771896068
documentDateModified: 2025-05-27 12:40:10
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:37:56
lastSeen: 2025-09-04 16:37:56
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 276f7173742a91381bb1cf6b090812d3f2fbd7e891e899bd455aa7c21fbbf55e
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip_1033
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 1124894
documentSize: 1843927
documentCompressRatio: 61.00534348702524
documentDateModified: 2025-01-08 16:24:24
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 324836
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 5 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 1124894
documentSize: 1843927
documentCompressRatio: 61.00534348702524
documentDateModified: 2025-01-08 16:24:24
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 237390
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-952823.pdf
documentType: pdf
documentCompressedSize: 1124894
documentSize: 1843927
documentCompressRatio: 61.00534348702524
documentDateModified: 2025-01-08 16:24:24
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: 952823
GSK COVID-19
Solutions
November 2020952823
GSK Strategy forCOVID-19 response includes both preventative(os) and therapeutic approaches
PREVENTION QQTREATMENTNf
1Pandemic Adjuvant2VIR 7831 (GSK4182136)
Vaccine Collaborations (NET R:Ua TelLFolgToTed[ToF=1WANoYi]ooTe
3Otilimab
: PVaivEed]Bess]Sl...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 108925
textDigestSHA256: 61e96b343e2bf2949c9f980c7f997d76f86fa107be4dfde9a78fb66f05a0c374
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
Archiefrij 7 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-952823-2020.11.09_-_COVID-19_GSK_Covid_Solutions_for_Governments_FinalSelectie_voor_-_-.pdf
documentType: pdf
documentCompressedSize: 1124894
documentSize: 1843927
documentCompressRatio: 61.00534348702524
documentDateModified: 2024-08-27 10:35:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: leeg!
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: n/a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 43277
textDigestSHA256: leeg!
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-952823
(dit is ook een speeltuin)